Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.36 |
| ▸ | PRKCG | P05129 | 1/20 | 0.36 |
| ▸ | PRKCB | P05771 | 1/20 | 0.36 |
| ▸ | PRKCA | P17252 | 1/20 | 0.36 |
| ▸ | PRKCH | P24723 | 1/20 | 0.36 |
| ▸ | PRKCI | P41743 | 1/20 | 0.36 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.36 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.36 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.36 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.36 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3626556 | 0.98 | ACE2 (0.43) | ACE2OPRM1PRKD3PRKCGPRKCB | |
| SCHEMBL2104704 | 0.98 | ACE2 (0.43) | ACE2OPRM1PRKD3PRKCGPRKCB | |
| SCHEMBL2102512 | 0.94 | MAPT (0.34) | ACE2PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL19276439 | 0.91 | ACE2 (0.41) | ACE2OPRM1PRKD3PRKCGPRKCB | |
| SCHEMBL15821782 | 0.82 | LMNA (0.46) | LMNA | |
| SCHEMBL14388597 | 0.82 | — | — | |
| SCHEMBL15821783 | 0.82 | LMNA (0.46) | LMNA | |
| SCHEMBL4302933 | 0.80 | LMNA (0.48) | EPHX1SPHK1LMNAALDH1A1 | |
| SCHEMBL4303893 | 0.80 | LMNA (0.48) | EPHX1SPHK1LMNAALDH1A1 | |
| SCHEMBL4304766 | 0.80 | LMNA (0.48) | EPHX1SPHK1LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090270288-A1 | ALKYL ACETAL COMPOUND, PROCESS FOR PRODUCING THE SAME, AND LUBRICATING OIL COMPOSITION | IDEMITSU KOSAN CO., LTD. (JP) | 2009-10-29 | — | — | US | claimed |
| US-8158564-B2 | Alkyl acetal compound, process for producing the same, and lubricating oil composition | IDEMITSU KOSAN CO., LTD. (JP) | 2012-04-17 | — | — | US | disclosed |
| US-7838692-B2 | Alkyl acetal compound, process for producing the same, and lubricating oil composition | IDEMITSU KOSAN CO., LTD. (JP) | 2010-11-23 | — | — | US | disclosed |
| US-20090270288-A1 | ALKYL ACETAL COMPOUND, PROCESS FOR PRODUCING THE SAME, AND LUBRICATING OIL COMPOSITION | IDEMITSU KOSAN CO., LTD. (JP) | 2009-10-29 | — | — | US | disclosed |
| US-20080234152-A1 | Alkyl Acetal Compound, Process for Producing the Same, and Lubricating Oil Composition | IDEMITSU KOSAN CO., LTD. (JP) | 2008-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234152-A1 | Alkyl Acetal Compound, Process for Producing the Same, and Lubricating Oil Composition | AR, F12, GK | ACE2 4343/4885OPRM1 1469/4885PRKD3 1835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.